133 related articles for article (PubMed ID: 38462823)
41. A single centre retrospective study of low dose prophylaxis with extended half-life factor IX for severe haemophilia B.
Rampotas A; Desborough MJR; Raza-Burton S; Taylor S; Wilkinson A; Hall GW; Shapiro S; Curry N
Haemophilia; 2020 Mar; 26(2):278-281. PubMed ID: 32083769
[TBL] [Abstract][Full Text] [Related]
42. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
Davies A; Waylen A; Leary S; Thomas S; Pring M; Janssen B; Beynon R; Lang S; Schimansky S; Hurley K; Ness A
Oral Oncol; 2020 Feb; 101():104504. PubMed ID: 31835074
[TBL] [Abstract][Full Text] [Related]
43. The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies.
Skinner MW; Négrier C; Paz-Priel I; Chebon S; Jiménez-Yuste V; Callaghan MU; Lehle M; Niggli M; Mahlangu J; Shapiro A; Shima M; Campinha-Bacote A; Levy GG; Oldenburg J; von Mackensen S; Pipe SW
Haemophilia; 2021 Sep; 27(5):854-865. PubMed ID: 34171159
[TBL] [Abstract][Full Text] [Related]
44. rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B: Post hoc analysis of B-LONG using haemophilia-specific quality of life questionnaires.
Astermark J; Hermans C; Ezzalfani M; Aballéa S; Santagostino E; Hakimi Z; Nazir J
Haemophilia; 2022 Jan; 28(1):18-26. PubMed ID: 34761474
[TBL] [Abstract][Full Text] [Related]
45. Practical Implications of Factor IX Gene Transfer for Individuals with Hemophilia B: A Clinical Perspective.
Miesbach W; Sawyer EK
Hum Gene Ther Clin Dev; 2018 Jun; 29(2):80-89. PubMed ID: 29624465
[TBL] [Abstract][Full Text] [Related]
46. Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa.
Santagostino E; Lentz SR; Busk AK; Regnault A; Iorio A
Haemophilia; 2014 Jul; 20(4):527-34. PubMed ID: 24471912
[TBL] [Abstract][Full Text] [Related]
47. Determining meaningful health-related quality-of-life improvement in persons with haemophilia A using the Haemophilia Quality of Life Questionnaire for Adults (Haem-A-QoL).
von Mackensen S; Catalani O; Asikanius E; Paz-Priel I; Lehle M; Trask P
Haemophilia; 2020 Nov; 26(6):1019-1030. PubMed ID: 33084166
[TBL] [Abstract][Full Text] [Related]
48. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.
Monahan PE; Sun J; Gui T; Hu G; Hannah WB; Wichlan DG; Wu Z; Grieger JC; Li C; Suwanmanee T; Stafford DW; Booth CJ; Samulski JJ; Kafri T; McPhee SW; Samulski RJ
Hum Gene Ther; 2015 Feb; 26(2):69-81. PubMed ID: 25419787
[TBL] [Abstract][Full Text] [Related]
49. Health-Related Quality of Life Among Patients With HR+/HER2- Early Breast Cancer.
Criscitiello C; Spurden D; Piercy J; Rider A; Williams R; Mitra D; Wild R; Corsaro M; Kurosky SK; Law EH
Clin Ther; 2021 Jul; 43(7):1228-1244.e4. PubMed ID: 34256965
[TBL] [Abstract][Full Text] [Related]
50. Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP study.
Daudén E; Pujol RM; Sánchez-Carazo JL; Toribio J; Vanaclocha F; Puig L; Yébenes M; Sabater E; Casado MA; Caloto MT; Aragón B;
Actas Dermosifiliogr; 2013 Nov; 104(9):807-14. PubMed ID: 23827342
[TBL] [Abstract][Full Text] [Related]
51. Examining the impact of haemophilia treatment on health-related quality of life.
Shaikh A; Pedra G; Cawson M; Wiseman C
Haemophilia; 2022 Sep; 28(5):796-805. PubMed ID: 35537107
[TBL] [Abstract][Full Text] [Related]
52. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
Martin A; Meads D; Griffiths AW; Surr CA
Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
[TBL] [Abstract][Full Text] [Related]
53. Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B.
Booth J; Oladapo A; Walsh S; O'Hara J; Carroll L; Garcia Diego DA; O'Mahony B
Haemophilia; 2018 Sep; 24(5):e322-e327. PubMed ID: 30091822
[TBL] [Abstract][Full Text] [Related]
54. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.
Gringeri A; Leissinger C; Cortesi PA; Jo H; Fusco F; Riva S; Antmen B; Berntorp E; Biasoli C; Carpenter S; Kavakli K; Morfini M; Négrier C; Rocino A; Schramm W; Windyga J; Zülfikar B; Mantovani LG
Haemophilia; 2013 Sep; 19(5):736-43. PubMed ID: 23731246
[TBL] [Abstract][Full Text] [Related]
55. Real-world data demonstrate improved bleed control and extended dosing intervals for patients with haemophilia B after switching to recombinant factor IX Fc fusion protein (rFIXFc) for up to 5 years.
Shapiro A; Chaudhury A; Wang M; Escobar M; Tsao E; Barnowski C; Feng J; Jain N; Quon DV
Haemophilia; 2020 Nov; 26(6):975-983. PubMed ID: 33012060
[TBL] [Abstract][Full Text] [Related]
56. Association between in-hospital frailty and health-related quality of life after stroke: the Nor-COAST study.
Wæhler IS; Saltvedt I; Lydersen S; Fure B; Askim T; Einstad MS; Thingstad P
BMC Neurol; 2021 Mar; 21(1):100. PubMed ID: 33663430
[TBL] [Abstract][Full Text] [Related]
57. Social/economic costs and quality of life in patients with haemophilia in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
[TBL] [Abstract][Full Text] [Related]
58. Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study.
Panés J; Domènech E; Aguas Peris M; Nos P; Riestra S; Juliá de Páramo B; Cea-Calvo L; Romero C; Marín-Jiménez I
J Gastroenterol Hepatol; 2017 Nov; 32(11):1818-1824. PubMed ID: 28370253
[TBL] [Abstract][Full Text] [Related]
59. Limited health literacy results in lower health-related quality of life in spine patients.
Koole D; Lans A; Lang JH; de Groot TM; Borkhetaria P; Verlaan JJ; Schwab JH; Tobert DG
Spine J; 2024 Feb; 24(2):263-272. PubMed ID: 37774984
[TBL] [Abstract][Full Text] [Related]
60. New and improved AAVenues: current status of hemophilia B gene therapy.
Brimble MA; Reiss UM; Nathwani AC; Davidoff AM
Expert Opin Biol Ther; 2016; 16(1):79-92. PubMed ID: 26524468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
